Projects per year
Personal profile
Biography
Greg Moore is Head of IBD at Monash Medical Centre in Melbourne and a Senior Lecturer in the Department of Medicine, Monash University.
He is Chair of the Austrlaian Inflammatory Bowel Diseases Association and a Board member of Crohn's and Colitis Australia and Chair of the Medical and Scientific Committee of CCA.
He graduated from Monash University and completed Gastroenterology training at Monash Medical Centre and St. Vincent's Hospital Melbourne.
He then undertook a basic science PhD at the University of Melbourne, and returned to found the Inflammatory Bowel Diseases Unit at Monash Medical Centre in 2007 where he oversees a multi-disciplinary IBD clinic providing tertiary referral services to the South East of Melbourne and country Victoria.
Greg combines private practice with coordinating clinical trials, undertaking ongoing research, supervising PhD and BMedSci students, and is an active undergraduate and post-graduate teacher.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis
13/10/22 → 12/10/27
Project: Research
-
Exploring the Impact of Trauma and Psychosocial Processes on the Quality of Life in Individuals Living with Inflammatory Bowel Disease
Glynn, H., Apputhurai, P., Moore, G. T. & Knowles, S. R., Sep 2022, In: Journal of Gastrointestinal and Liver Diseases. 31, 3, p. 301-308 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Fourier-Transform Infra-Red Microspectroscopy Can Accurately Diagnose Colitis and Assess Severity of Inflammation
Keung, C., Heraud, P., Kuk, N., Lim, R., Sievert, W., Moore, G. & Wood, B., 1 Mar 2022, In: International Journal of Molecular Sciences. 23, 5, 19 p., 2849.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Impact of a pharmacist-led thiopurine monitoring service in outpatients with inflammatory bowel disease
Rodda, S. E., Fildes, K. J., Shelton, E., Goldberg, R. & Moore, G. T., 2022, (Accepted/In press) In: Internal Medicine Journal. 8 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
Schulberg, J. D., Wright, E. K., Holt, B. A., Hamilton, A. L., Sutherland, T. R., Ross, A. L., Vogrin, S., Miller, A. M., Connell, W. C., Lust, M., Ding, N. S., Moore, G. T., Bell, S. J., Shelton, E., Christensen, B., De Cruz, P., Rong, Y. J. & Kamm, M. A., 1 Apr 2022, In: The Lancet Gastroenterology & Hepatology. 7, 4, p. 318-331 14 p.Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
Oral ulcers: thinking beyond inflammatory bowel disease
Sebastian, T., Tambakis, G., Moore, G. & Bell, S., Feb 2022, In: Internal Medicine Journal. 52, 2, p. 328-329 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Activities
- 1 Membership of an advisory panel/policy group/ board
-
Crohn's and Colitis Australia (External organisation)
Gregory Moore (Member)
2010 → …Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board